Sartorius (SARTF) Stock Price, News & Analysis

Company Overview

Sartorius AG is a Germany-based life science company that develops and supplies equipment, technologies and services for pharmaceutical, biotechnology and laboratory applications. Its offerings support the development, production and quality control of medicines, vaccines and other biological products.

The company’s products include laboratory instruments, balances, filtration systems, laboratory consumables, bioreactors, cell-culture technologies, fluid-management systems, sensors and analytical equipment. Sartorius also provides single-use technologies and other solutions designed to help biopharmaceutical manufacturers improve production processes and maintain quality standards.

Founded in 1870 by Florenz Sartorius in Göttingen, Germany, the company has expanded into an international supplier serving pharmaceutical and biotechnology companies, research institutions, universities and other laboratories. Sartorius operates across major life science markets in Europe, North America, Asia and other regions worldwide.

Key Stats

• Today's Range: $243.86 to $243.86
• 50-Day Range: $212.80 to $243.86
• 52-Week Range: $181.58 to $243.86
• Volume: N/A
• Average Volume: 223 shs
• Market Capitalization: $8.35 billion
• P/E Ratio: 113.42
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/16/2025
• Today: 9/25/2026
• Next Earnings (Estimated): 10/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:SARTF
• Previous Symbol: NASDAQ:SARTF
• CIK: N/A
• Web: www.sartorius.com
• Phone: 495513080
• Fax: 49-55-1308-3289
• Employees: 13,528
• Year Founded: 1870

Profitability

• EPS (Trailing Twelve Months): $2.15
• Trailing P/E Ratio: 113.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $90.90 million
• Net Margins: 3.82%
• Pretax Margin: 8.16%
• Return on Equity: 8.19%
• Return on Assets: 3.15%

Debt

• Debt-to-Equity Ratio: 0.89
• Current Ratio: 0.95
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $3.66 billion
• Price / Sales: 2.28
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 34,230,000
• Free Float: N/A
• Market Cap: $8.35 billion
• Optionable: Not Optionable
• Beta: 0.98